Citation Impact
Citing Papers
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
2006 StandoutScience
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Reconstituting Organ-Level Lung Functions on a Chip
2010 StandoutScience
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 Standout
High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer’s disease
2016
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer’s disease
2015
Genetic clues to the pathogenesis of Parkinson's disease
2004
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Presenilins are essential for regulating neurotransmitter release
2009 StandoutNatureNobel
The Clinical Spectrum of Lymphatic Disease
2008
Parkinson's disease
2021 Standout
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
2013
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
2005
The genetics of Parkinson disease: implications for neurological care
2006
Tau haplotypes regulate transcription and are associated with Parkinson's disease
2004
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17
2006
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
2008
Diagnostic delay in Parkinson's disease caused by PRKN mutations
2019
Molecular pathogenesis of Parkinson disease: insights from genetic studies
2009
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
2012 Standout
Alzheimer's disease
2011 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Genetics of Parkinson's disease
2005
Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin
2004
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
2008 Standout
Olfactory testing in parkinsonism
2004
Magnetic nanoparticles for theragnostics
2009
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
2007
Frontotemporal Lobar Degeneration
2005
Parkinson's disease
2009 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Parkin Disease
2013
Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)
2007
High‐field magnetic resonance imaging of brain iron: birth of a biomarker?
2004
PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism
2004
Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine
1996
Parkinson's disease
2015 Standout
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism
2006
Parkinson's Disease: Gene Therapies
2012
Update on the genetics of Parkinson's disease
2007
Autophagy in Human Health and Disease
2013 Standout
Atmospheric Aerosols: Composition, Transformation, Climate and Health Effects
2005 Standout
The neuropathology of genetic Parkinson's disease
2012
Narcolepsy in orexin Knockout Mice
1999 Standout
Mechanisms of mitophagy
2010 Standout
Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease
2007
The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
1999 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Pathogenetic mechanisms of parkin in Parkinson's disease
2004
Lewy body Parkinson's disease in a large pedigree with 77Parkin mutation carriers
2005
Alzheimer's Disease
2010 Standout
Olfaction and Parkinson's syndromes: its role in differential diagnosis
2004
α-synuclein locus duplication as a cause of familial Parkinson's disease
2004 Standout
Genetics of Parkinson's disease and biochemical studies of implicated gene products: Commentary
2002
Parkinson's Disease and Parkinsonism: Neuropathology
2012
Genetics of Parkinson's disease and biochemical studies of implicated gene products
2002
Expanding insights of mitochondrial dysfunction in Parkinson's disease
2006
Imaging biomarkers in Parkinson's disease
2011
alpha-synuclein gene haplotypes are associated with Parkinson's disease
2001
A common LRRK2 mutation in idiopathic Parkinson's disease
2005 Standout
Genetics of Parkinsonʼs disease
2005
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
2009 Standout
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
2012
NARCOLEPSY
1996
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
2015 StandoutNature
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation
2005
Parkinson's Disease
2003 Standout
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
2003
Aging Analysis Reveals Slowed Tau Turnover and Enhanced Stress Response in a Mouse Model of Tauopathy
2008
Impaired dopamine release and synaptic plasticity in the striatum of PINK1 -deficient mice
2007
Increased Levels of Magnetic Iron Compounds in Alzheimer's Disease
2008
Antibody-Mediated Encephalitis
2018 Standout
Toxic Potential of Materials at the Nanolevel
2006 StandoutScience
Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis
2006
New Generation Adsorbents for Water Treatment
2012 Standout
A Century of Alzheimer's Disease
2006 StandoutScience
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
Mutations causing neurodegenerative tauopathies
2004
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability
2005
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
2005 StandoutScience
Apolipoprotein E controls the risk and age at onset of Parkinson disease
2004
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Magnetite pollution nanoparticles in the human brain
2016 Standout
Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65
2014
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Parkinson's Disease: Genetics and Pathogenesis
2011
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
2005 Standout
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
2008 Standout
Works of Naheed L. Khan being referenced
Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease
2005
Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow‐up over 10 years
2005
Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study
2002
Upregulation of dopamine D2 receptors in dopaminergic drug‐naive patients with parkin gene mutations
2006
Parkin disease: a phenotypic study of a large case series
2003
Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations
2008
The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease
2002
Prader-Willi and Angelman syndromes: update on genetic mechanisms and diagnostic complexities
1999
Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study
2002
Two large British kindreds with familial Parkinson’s disease: a clinico‐pathological and genetic study
2002
Frontotemporal lobar degeneration and ubiquitin immunohistochemistry
2004
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies
2003
Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: An 18F‐dopa PET progression study
2009
HISTOPATHOLOGY OF VGKC ANTIBODY–ASSOCIATED LIMBIC ENCEPHALITIS
2009
Parkinson's disease is not associated with the combined α‐synuclein/apolipoprotein E susceptibility genotype
2001
Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease
2004
Striatal dopamine D 2 receptors in patients with narcolepsy measured with PET and 11 C‐raclopride
1994
Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue
2003
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation
2005